ERIC PHELAN: Open Payments
NPI 1386192318 · ENDWELL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 75 payments from 15 companies in 2025. Trend: 2023 $381 · 2024 $586 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $284 |
| AstraZeneca Pharmaceuticals LP | 9 | $253 |
| GlaxoSmithKline, LLC. | 16 | $240 |
| Exact Sciences Corporation | 8 | $165 |
| Novo Nordisk Inc | 5 | $100 |
| Abbott Laboratories | 3 | $63 |
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Inspire Medical Systems, Inc. | 2 | $47 |
Products named: VRAYLAR, TRELEGY ELLIPTA, FARXIGA, Cologuard Collection Kit, The Cologuard Plus Collection Kit, AREXVY, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
